U.S. Markets close in 5 hrs 18 mins
  • S&P 500

    4,577.59
    +44.83 (+0.99%)
     
  • Dow 30

    35,310.01
    +281.36 (+0.80%)
     
  • Nasdaq

    14,552.58
    +212.33 (+1.48%)
     
  • Russell 2000

    2,082.06
    +19.28 (+0.93%)
     
  • Crude Oil

    87.00
    +0.04 (+0.05%)
     
  • Gold

    1,847.20
    +4.00 (+0.22%)
     
  • Silver

    24.61
    +0.38 (+1.56%)
     
  • EUR/USD

    1.1346
    -0.0001 (-0.0113%)
     
  • 10-Yr Bond

    1.8270
    0.0000 (0.00%)
     
  • Vix

    22.20
    -1.65 (-6.92%)
     
  • GBP/USD

    1.3644
    +0.0032 (+0.2374%)
     
  • USD/JPY

    114.0780
    -0.2750 (-0.2405%)
     
  • BTC-USD

    43,223.09
    +1,093.93 (+2.60%)
     
  • CMC Crypto 200

    1,028.66
    +33.39 (+3.36%)
     
  • FTSE 100

    7,564.44
    -25.22 (-0.33%)
     
  • Nikkei 225

    27,772.93
    +305.70 (+1.11%)
     

The Key Behind Vertex's Great Q3 Results

·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Vertex Pharmaceuticals (NASDAQ: VRTX) announced strong growth in its third-quarter update on Nov. 2, 2021. In this Motley Fool Live video recorded on Nov. 3, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the key behind Vertex's great Q3 results. Keith Speights: There was another big biotech that also reported earnings.